References
- J. Med. Chem. v.6 Johnston, T. P.;McCaleb, G. S.;Opliger, P. S.;Montgomery, I. A.
- J. Med. Chem. v.9 Johnston, T. P.;McCaleb, G. S.;Opliger, P. S.;Montgomery, I. A.
- J. Med. Chem. v.14 Johnston, T. P.;McCaleb, G. S.;Opliger, P. S.;Montgomery, I. A.
- J. Med. Chem. v.20 Johnston, T. P.;McCaleb, G. S.;Opliger, P. S.;Montgomery, I. A.
- J. Pharm. Soc. v.24 Kim, J. C.;Cho, I. S.
- J. Pharm. Soc. v.27 Kim, J. C.;Youn, I. K.;Koh, Y. S.;Yoon, U. C.;Pack, M. Y.;Moon, K. H.
- Arch. Pharm. Res. v.6 Kim, J. C.;Kim, M. S.;Lee, H. K.
- J. Pharm. Soc. v.28 Kim, J. C.;Park, M. T.;Shin, H. D.;Koh, Y. S.;Yoon, U. C.;Ryu, S. H..;Moon, K. H.;Kim, M. S.
- J. Pharm. Soc. v.6 Kim, J. C.;Choi, S. K.;Cho, I. S.;Yu, D. S.;Ryu, S. H.;Moon, K. H.
- Arch. Pharm. Res. v.9 Kim, J. C.;Choi, S. K.;Moon, S. H.
- Korean J. Med. Chem. v.3 Kim, J. C.;Lee, J. C.;Nha, C. S.
- Bull. Korean Chem. Soc. v.14 Kim, J. C.;Park, J. I.;Hur, T. H.
- Cancer Treat. Rep. v.60 Montgomery, J. A.
- J. Korean Chem. Soc. v.35 Kim, J. C.;Cho, I. S.;Choi, S. K.
- J. Korean Chem. Soc. v.35 Won, M. S.;Kim, J. C.;Shim, Y. B.
- Bull. Korean Chem. Soc. v.13 Won, M. S.;Kim, J. C.;Shim, Y. B.
- J. Med. Chem. Kim, J. C.;Lim, Y. G.;Min, B. T.
- J. Org. Chem. v.46 Singer, S. S.;Cole, B. B.
Cited by
- Preparation of N'-Substituted Anilino-N-Methyl-N-Nitorsoureas as Candidate Antitumor Agents vol.17, pp.6, 1994, https://doi.org/10.1007/bf02979118
-
Synthesis and antitumor evaluation of
$\alphamethylene-\gamma-butyrolactone-linked$ to 5-substituted uracil nucleic acid bases vol.19, pp.3, 1996, https://doi.org/10.1007/bf02976897 - Potential Antitumor ${\alpha}$-methylene-${\gamma}$-butyrolactone-bearing nucleic acid bases. 2. synthesis of $5^I-Methyl-5^I$-[2-(5-substituted uracil-1-yl)ethyl]-$2^I-oxo-3^I$-methylenetetrahydrofur vol.20, pp.3, 1994, https://doi.org/10.1007/bf02976153